Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-08

Clinical Trial Update: Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating fertility preservation using tamoxifen and letrozole in estrogen-sensitive tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Letrozole (letrozole)
  • Tamoxifen (tamoxifen)

Snippet

Sponsor: University of California, San Francisco | Conditions: Infertility | Phase 3 | Status: RECRUITING